Ligand validation:6YC1

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6YC1_OLC_D_308	48%	43%	0.122	0.943	1.23	0.98	1	2	0	56%	0.56
6YC1_OLC_B_301	27%	52%	0.179	0.845	0.98	0.89	1	1	4	88%	0.88
6YC1_OLC_E_307	22%	43%	0.217	0.906	1.19	1.03	1	2	0	60%	0.6
6YC1_OLC_B_307	18%	46%	0.229	0.884	1.15	0.96	1	2	0	64%	0.64
6YC1_OLC_C_309	18%	45%	0.181	0.83	1.18	0.94	1	2	1	64%	0.64
6YC1_OLC_D_301	17%	46%	0.223	0.855	1.1	0.98	1	1	2	72%	0.72
6YC1_OLC_E_303	15%	87%	0.178	0.858	0.29	0.39	-	-	0	32%	0.32
6YC1_OLC_A_301	15%	82%	0.163	0.834	0.36	0.44	-	-	0	36%	0.36
6YC1_OLC_A_306	14%	41%	0.19	0.815	1.21	1.09	1	2	0	60%	0.6
6YC1_OLC_C_310	14%	88%	0.178	0.854	0.3	0.37	-	-	0	28%	0.28
6YC1_OLC_A_317	13%	51%	0.304	0.894	1.1	0.79	1	-	1	76%	0.76
6YC1_OLC_A_318	13%	50%	0.258	0.838	1.08	0.87	1	-	0	80%	0.8
6YC1_OLC_C_301	12%	48%	0.261	0.818	1.02	0.98	1	1	0	84%	0.84
6YC1_OLC_C_306	11%	51%	0.218	0.761	1.02	0.89	1	1	0	88%	0.88
6YC1_OLC_C_302	11%	49%	0.226	0.777	1.05	0.92	1	2	1	80%	0.8
6YC1_OLC_C_305	10%	55%	0.297	0.824	0.94	0.81	1	2	3	92%	0.92
6YC1_OLC_A_307	10%	87%	0.218	0.847	0.27	0.43	-	-	0	28%	0.28
6YC1_OLC_E_305	10%	47%	0.301	0.838	1.07	0.98	1	1	0	80%	0.8
6YC1_OLC_A_304	9%	37%	0.201	0.782	1.31	1.18	1	2	0	52%	0.52
6YC1_OLC_D_306	9%	43%	0.227	0.768	1.12	1.1	1	1	0	72%	0.72
6YC1_OLC_D_307	9%	47%	0.228	0.767	1.13	0.92	1	1	0	72%	0.72
6YC1_OLC_E_301	8%	54%	0.274	0.755	0.93	0.86	1	1	0	100%	1
6YC1_OLC_B_304	8%	54%	0.208	0.682	0.95	0.84	1	1	1	100%	1
6YC1_OLC_D_305	8%	54%	0.22	0.692	0.94	0.85	1	1	0	100%	1
6YC1_OLC_A_302	7%	50%	0.266	0.746	0.99	0.93	1	2	2	88%	0.88
6YC1_OLC_B_305	7%	48%	0.23	0.72	1.05	0.95	1	2	0	80%	0.8
6YC1_OLC_D_310	7%	56%	0.276	0.723	0.93	0.77	1	1	1	100%	1
6YC1_OLC_B_302	6%	44%	0.3	0.802	1.2	0.96	1	1	0	64%	0.64
6YC1_OLC_C_307	6%	49%	0.272	0.744	1.05	0.94	1	1	0	80%	0.8
6YC1_OLC_D_309	5%	89%	0.198	0.736	0.34	0.29	-	-	0	28%	0.28
6YC1_OLC_B_306	4%	50%	0.3	0.722	1.03	0.92	1	1	0	84%	0.84
6YC1_OLC_C_303	4%	37%	0.238	0.702	1.41	1.06	1	1	0	48%	0.48
6YC1_OLC_D_302	3%	42%	0.284	0.702	1.22	1.04	1	1	0	64%	0.64
6YC1_OLC_C_308	3%	50%	0.319	0.683	1.03	0.92	1	1	0	88%	0.88
6YC1_OLC_B_308	3%	74%	0.232	0.693	0.47	0.54	-	-	0	28%	0.28
6YC1_OLC_E_304	3%	84%	0.262	0.652	0.28	0.48	-	-	2	64%	0.64
6YC1_OLC_A_303	3%	54%	0.337	0.65	0.96	0.83	1	1	1	100%	1
6YC1_OLC_D_304	3%	38%	0.229	0.625	1.35	1.07	1	1	0	52%	0.52
6YC1_OLC_E_308	3%	90%	0.22	0.666	0.33	0.28	-	-	0	24%	0.24
6YC1_OLC_E_309	1%	52%	0.37	0.57	1.03	0.84	1	1	1	88%	0.88
6YC1_OLC_E_310	1%	48%	0.461	0.67	1.07	0.94	1	1	0	80%	0.8
6YC1_OLC_E_306	1%	42%	0.466	0.682	1.22	1.03	1	1	0	60%	0.6
6YC1_OLC_A_305	0%	52%	0.301	0.331	0.99	0.88	1	2	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6YC1

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate